| Stage | GKOS | % of rev | KMX | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $211M | 100.00% | $7.9B | 100.00% | KMX ×37.33 |
| Gross profit | $180M | 85.23% | $799M | 10.15% | GKOS +75.1pp |
| Operating income | $828,000 | 0.39% | $101M | 1.28% | KMX +0.9pp |
| Pre-tax income | $2M | 1.10% | $223M | 2.83% | KMX +1.7pp |
| Net income | $2M | 0.96% | $165M | 2.10% | KMX +1.1pp |
| Stage | GKOS | KMX | Gap · A − B |
|---|---|---|---|
| Revenue | $211M100.00% | $7.9B100.00% | KMX ×37.33 |
| Gross profit | 85.23%$180M | 10.15%$799M | GKOS +75.1pp |
| Operating income | 0.39%$828,000 | 1.28%$101M | KMX +0.9pp |
| Pre-tax income | 1.10%$2M | 2.83%$223M | KMX +1.7pp |
| Net income | 0.96%$2M | 2.10%$165M | KMX +1.1pp |
None
No disclosed counterparties: GKOS.